Ling Yin

5PUBLICATIONS
16CO-AUTHORS
Innate immunityRadiation therapyRadiation and matterElectrochemical energy storage and conversionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 19, 2024
In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer.

Xu Feng, Chang Yang, Yuanjian Huang

|Feb 05, 2024
Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy.

Ling Yin, Xiaoding Hu, Guangsheng Pei

|Dec 06, 2023
RAD54L2-mediated DNA damage avoidance pathway specifically preserves genome integrity in response to topoisomerase 2 poisons.

Huimin Zhang, Yun Xiong, Yilun Sun

|Apr 13, 2023
Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway.

Jeong-Min Park, Huimin Zhang, Litong Nie

|Jun 15, 2022
Integrated screens uncover a cell surface tumor suppressor gene KIRREL involved in Hippo pathway.

Chao Wang, Xu Feng, Dan Su

Pageof 1

Frequent Collaborators

5 joint publications

Junjie Chen

3 joint publications

Xu Feng

2 joint publications

Jeong-Min Park

1 joint publications

Huimin Zhang